Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för ceftolozane. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

9 träffar

Bibliografisk träff 2018-03-09

Ceftolozane/tazobactam: place in therapy.

Giacobbe DR, Bassetti M, De Rosa FG, Del Bono V, Grossi PA, Menichetti F, Pea F, Rossolini GM, Tumbarello M, Viale P, Viscoli C, ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva).

Expert Rev Anti Infect Ther · research support, non-u.s. gov't; review; journal article · DOI 10.1080/14787210.2018.1447381

Bibliografisk träff 2018-03-08

Safety, Tolerability, and Pharmacokinetics of 3 g of Ceftolozane/Tazobactam in Healthy Adults: A Randomized, Placebo-Controlled, Multiple-Dose Study.

Yu B, Adedoyin A, Hershberger E, Caro L, Xiao A, Rhee EG, Huntington JA.

Clin Pharmacol Drug Dev · research support, non-u.s. gov't; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1002/cpdd.429

Bibliografisk träff 2018-01-24

Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa.

Shields RK, Clancy CJ, Pasculle AW, Press EG, Haidar G, Hao B, Chen L, Kreiswirth BN, Nguyen MH.

J Clin Microbiol · comparative study; research-article; evaluation study; journal article; research support, n.i.h., extramural · DOI 10.1128/jcm.01093-17

Bibliografisk träff 2018-01-01

Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Novel Therapy for Multidrug Resistant Gram Negative Infections in Children.

Rodriguez BA, Girotto JE, Nicolau DP.

Curr Pediatr Rev · review; journal article · DOI 10.2174/1573396314666180308150908

Bibliografisk träff 2017-11-22

<i>In Vitro</i> Comparison of Ceftolozane-Tazobactam to Traditional Beta-Lactams and Ceftolozane-Tazobactam as an Alternative to Combination Antimicrobial Therapy for Pseudomonas aeruginosa.

Goodlet KJ, Nicolau DP, Nailor MD.

Antimicrob Agents Chemother · research-article; multicenter study; journal article · DOI 10.1128/aac.01350-17

Bibliografisk träff 2017-11-22

Activity of Ceftolozane-Tazobactam and Ceftazidime-Avibactam against Beta-Lactam-Resistant Pseudomonas aeruginosa Isolates.

Humphries RM, Hindler JA, Wong-Beringer A, Miller SA.

Antimicrob Agents Chemother · brief-report; multicenter study; journal article · DOI 10.1128/aac.01858-17

Bibliografisk träff 2017-10-07

Cross-reactivity in β-Lactam Allergy.

Zagursky RJ, Pichichero ME.

J Allergy Clin Immunol Pract · review; journal article · DOI 10.1016/j.jaip.2017.08.027

Bibliografisk träff 2017-10-05

Successful treatment of three severe MDR or XDR Pseudomonas aeruginosa infections with ceftolozane/tazobactam.

Xipell M, Bodro M, Marco F, Martínez JA, Soriano A.

Future Microbiol · journal article; case reports · DOI 10.2217/fmb-2017-0018

Bibliografisk träff 2017-07-06

In vitro activity of ceftolozane/tazobactam in combination with other classes of antibacterial agents.

Jacqueline C, Howland K, Chesnel L.

J Glob Antimicrob Resist · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jgar.2017.04.003